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Background
Hypertrophic cardiomyopathy (HCM) is a highly hetero-
genous disease both genotypically and phenotypically.
Cardiovascular magnetic resonance (CMR) with late
gadolinium enhancement (LGE) for fibrosis detection
and adenosine stress perfusion are key techniques for
HCM phenotyping. Recent advances in DNA sequencing,
in particular high throughput next generation sequencing
(NGS), have enabled more extensive genetic analysis of
larger cohorts of patients. We sought to assess the link
between genotype and the microvascular circulation in a
cohort of patients with HCM.
Methods
We recruited 288 patients with HCM according to stan-
dard criteria, who were undergoing clinical CMR. All
patients had assessment of LV volumes, mass and function
and LGE, except 1 for volumes and 2 for LGE. Overall,
214 (74%) also underwent adenosine stress perfusion.
Detailed demographic and outcome data were collected
over a mean of 3 years follow up. 120 genes with a known
or putative role in cardiomyopathy were sequenced in
every patient using SureSelect target DNA capture and
SOLiD next-generation sequencing, and variants were iden-
tified using GATK and LifeScope. Subjects were stratified
according to the presence or absence of a likely causative
genetic variant in the principal sarcomeric HCM genes.
Results
Clinical data are presented in table 1 and genetic data in
table 2. Thirty-five percent of patients carried a likely
causative variant (genotype positive). Genotype positive
patients were younger at diagnosis (p = 0.005), with a
trend to a higher death rate during follow up. Adenosine
stress perfusion was more frequently abnormal in geno-
type positive patients (82% v. 64%, p = 0.015). LV mass
index was on average 12% greater in genotype negative
patients (p = 0.005). There were no significant differ-
ences between groups for LV volumes, maximum wall
thickness, or extent of LGE.
Conclusions
The main finding of this study is that genotype positive
patients are more likely to have abnormal myocardial
perfusion. It is known that genotype positive HCM
patients have a higher rate of sudden cardiac death (and
a trend towards death was seen in this study), and this
has been postulated to be related to ischemia. Our find-
ing that sarcomeric variants were associated with lower
LV mass was unexpected and is worthy of further study
given the comparatively large size of this cohort. Previous
studies have highlighted the association between maxi-
mum LV wall thickness and extent of LGE with the pre-
sence of a known HCM mutation, but this finding was
not replicated in the present study. More comprehensive
genetic analyses enabled by next generation technologies,
coupled with cutting-edge phenotypic evaluation, may
enable the dissection of genotype-phenotype relation-
ships in HCM.
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Table 1 Genotype Phenotype correlations in HCM [mean (SD) unless stated]
Variable Genotype POSITIVE Genotype NEGATIVE Significance (NS = not significant)
Number (%) 102 (35%) 186 (65%)
Male sex (%) 75 (73.5%) 137 (73.7%) NS
BSA (m2) 1.97 (0.22) 1.94 (0.22) NS
Age at CMR (years) 54.6 (12.8) 59.2 (13.4) p = 0.005
Positive family history (%) 22 (21.6%) 35 (18.8%) NS
Length of follow up (months) 37.6 (17.0) 40.8 (20.4) NS
Dead (%) 6 (5.9%) 4 (2.2%) NS
LVEDV (mL) 137.8 (33.6) 134.2 (37.2) NS
LVESV (mL) 34.4 (16.0) 36.2 (19.4) NS
LVSV (mL) 103.4 (25.6) 98.0 (25.0) NS (p = 0.08)
LVEF (%) 75.5 (8.5) 74.1 (8.5) NS
LV Mass (g) 174.8 (54.6) 191.6 (66.2) p = 0.030
LVEDVi (mL/m2) 69.9 (14.5) 69.0 (17.0) NS
LVESVi (mL/m2) 17.4 (7.8) 18.4 (9.2) NS
LV mass index (g/m2) 88.1 (27.6) 98.5 (31.2) p = 0.005
STRESS PERFUSION SCAN POSITIVE 65/79 (82.3%) 87/135 (64.4%) p = 0.015
Max wall thickness (mm) 18.6 (3.7) 19.1 (5.1) NS
Base most affected (%) 68 (66.7%) 103 (55.4%) NS (p = 0.08)
Apex most affected (%) 15 (14.7%) 39 (21.0%) NS
Septum most affected (%) 92 (90%) 154 (82.8%) NS
LGE score (%)
0 21 (21%) 36 (20%) NS
1 36 (35%) 64 (35%) NS
2 37 (36%) 68 (37%) NS
3 8 (8%) 16 (9%) NS
LGE score: 0=none, 1= minimal, 2= moderate, 3= widespread - as assessed by CMR level 3 accredited observers
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